CNSX:LOVE Cannara Biotech (LOVE) Stock Price, News & Analysis → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Free LOVE Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume69,070 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Cannara Biotech alerts: Email Address Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… About Cannara Biotech Stock (CNSX:LOVE)Cannara Biotech Inc. is a vertically integrated cannabis company building the largest indoor cannabis cultivation facility in Quebec, a modern and secure 625,000 square foot facility. Leveraging Quebec’s low electricity costs, Cannara will produce high-grade indoor cannabis, specializing in derivative products and brands.Read More Ad Traders Agencytop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.Click here now for the full details of this stock that’s set to rocket in the AI revolution… LOVE Stock News HeadlinesApril 22, 2024 | finance.yahoo.comInsider Spends US$434k Buying More Shares In LovesacApril 16, 2024 | finance.yahoo.comThe Lovesac Company (NASDAQ:LOVE) Q4 2024 Earnings Call TranscriptApril 24, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.April 12, 2024 | finance.yahoo.comQ4 2024 Lovesac Co Earnings CallApril 12, 2024 | finance.yahoo.comThe Lovesac Co (LOVE) Q4 2024 Earnings Call Transcript Highlights: Navigating Industry ...April 12, 2024 | finance.yahoo.comThe Lovesac Company (NASDAQ:LOVE) Shares Could Be 38% Below Their Intrinsic Value EstimateApril 11, 2024 | fool.comLovesac (LOVE) Q4 2024 Earnings Call TranscriptApril 9, 2024 | wsj.comCannara Biotech Inc.April 24, 2024 | Traders Agency (Ad)top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligence stock[/lin] is NOT Microsoft, Google, Amazon or Apple. Nope — his research is pointing to a tiny, under-the-radar stock that’s trading for just a few dollars right now… And could soon shoot to the moon, handing early investors a windfall.March 20, 2024 | finance.yahoo.comCannara Biotech Inc.'s (CVE:LOVE) Stock Been Rising: Are Strong Financials Guiding The Market?March 11, 2024 | finance.yahoo.comReturns On Capital Are Showing Encouraging Signs At Lovesac (NASDAQ:LOVE)February 25, 2024 | benzinga.comCannara Biotech Stock (OTC:LOVFF), Insider Trading ActivityFebruary 21, 2024 | finance.yahoo.comWith EPS Growth And More, Cannara Biotech (CVE:LOVE) Makes An Interesting CaseFebruary 13, 2024 | finance.yahoo.comShareholders in Lovesac (NASDAQ:LOVE) are in the red if they invested three years agoFebruary 10, 2024 | fool.com4 Appealing Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market DipFebruary 7, 2024 | benzinga.comCannara Biotech Q1 Results: Revenue, Net Income And Market Share Up, Quarter Also Marks Company's First Export SaleJanuary 30, 2024 | finanznachrichten.deCannara Biotech Inc.: Cannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market ExpansionJanuary 30, 2024 | finance.yahoo.comCannara Biotech Announces Record-Breaking Q1 2024 Results: Continued Robust Growth and Market ExpansionJanuary 27, 2024 | fool.com4 Spectacular Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear-Market DipJanuary 23, 2024 | finance.yahoo.comThe past five years for Cannara Biotech (CVE:LOVE) investors has not been profitableJanuary 8, 2024 | finance.yahoo.comCannara Biotech Announces Engagement of Market Maker Services from Independent Trading Group ("ITG")January 2, 2024 | finance.yahoo.comFounder and CEO of The Lovesac Company Publishes Candid Origin StoryDecember 21, 2023 | benzinga.comCannara Biotech Stock (OTC:LOVFF) Dividends: History, Yield and DatesDecember 18, 2023 | finance.yahoo.comThe Lovesac Company Publishes 2023 ESG ReportDecember 18, 2023 | finance.yahoo.comThe Lovesac Company (NASDAQ:LOVE) Looks Just Right With A 50% Price JumpDecember 15, 2023 | finance.yahoo.comLovesac Unveils Swarovski Crystal Embellished Footsac, Perfect for Holiday GiftingDecember 8, 2023 | finance.yahoo.comInsiders of Lovesac Getting Good Value On Their US$1.26m InvestmentSee More Headlines Receive LOVE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cannara Biotech and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeCNSX SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolCNSX:LOVE CUSIPN/A CIKN/A Webcannara.ca PhoneN/AFaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key CompetitorsAbattis BioceuticalsCNSX:ATTAgraflora Organics InternationalCNSX:AGRAAmplify Alternative Harvest ETFCNSX:MJBio-Rad LaboratoriesCNSX:BIOBlueberries MedicalCNSX:BBMView All Competitors LOVE Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Cannara Biotech own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cannara Biotech investors own include FSD Pharma (HUGE), Aurora Cannabis (ACB), Cross Timbers Royalty Trust (CRT), Emerald Health Therapeutics (EMH), HEXO (HEXO), Harvest One Cannabis (HVT) and KushCo (KSHB). How do I buy shares of Cannara Biotech? Shares of LOVE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (CNSX:LOVE) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Crypto for 2024InvestorPlaceDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cannara Biotech Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.